Tralokinumab for AD was associated with sustained improvements in disease severity and no new safety signals at 12 months in a real-life study.

Congenital TORCH infections appear to be associated with an increased risk for intellectual disability and autism.

The lifetime risk for heart failure is increasing, and prevalence is projected to continue accelerating, according to a recent report.

While TB and meningitis are rare among patients receiving systemic psoriasis therapies, IL-17 inhibitors increase the risk for candidiasis.

The novel hyaluronic acid-based injection ANN0032 is noninferior to an active control treatment in patients with moderate to severe neck wrinkles.

Most patients with BRCA1/2 pathogenic variants who received navigation for cascade genetic testing completed genetic testing by 18 months.

The FDA has expanded the approval of Rhapsido (remibrutinib) to include symptomatic dermographism in adults inadequately controlled by H1 antihistamines, backed by phase 3 RemIND trial data.

The use of vibration anesthesia in patients undergoing cryotherapy was associated with pain reductions when compared with cryotherapy alone.

Patients with moderate to severe plaque psoriasis who received any dosage of SHR-1139 had improvements in skin clearance at ...

The only baseline characteristic that predicted super response to topical ruxolitinib in patients with nonsegmental vitiligo was disease activity.

All enpatoran dosages were associated with improvements in skin manifestations of cutaneous lupus erythematosus and systemic ...

Izokibep was effective in reducing disease activity among patients with HS, including those who switched to izokibep from ...